GRANZER HEINZ ULRICH -  

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 9.902.750 387.500 1
2017 0 6.000.000 267.188 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
EUROPEAN CANCER PATIENT COALITION1
EXEVIR BIO1
INC RESEARCH UK1
ISA THERAPEUTICS BV1
KATHOLIEKE UNIVERSITEIT LEUVEN1
MILLIPORE SAS1
TTOPSTART BV1
VIB VZW1

Constancy:

Total number of partners: 8
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 8
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2021-12-01ExeVir's XVR011, a best in class nanobody-based biology that broadly neutralizes SARS-COV-1 and SARS-COV-2 XVR011 Phase 2participant9.902.7504
2017-12-01A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer IMMUNISAparticipant6.000.0006